Jonathan B Koea1. 1. Department of Surgery, North Shore Hospital, Auckland, New Zealand. jonathan.koea@waitematadhb.govt.nz
Abstract
OBJECTIVES: Hepatic incidentalomas (HI) are asymptomatic lesions detected incidentally during investigations for other pathologies. This prospective series outlines the management and outcomes of 121 HI managed over 7 years. METHODS: Data were recorded prospectively on 121 patients referred between 2003 and 2010 for assessment of HI out of 1081 patients referred for a hepatic resection. Patients were reviewed in multidisciplinary meetings and investigated with tumour markers and radiological investigations. HI were classified as hypo- or hypervascular depending on arterial phase CT scan findings. Univariate and multivariate analysis was performed to define predictive factors for malignancy. RESULTS: Forty HI were hypovascular, 35 were benign (18 cysts, 12 focal fatty sparing, 1 fetal lobulation and 4 solitary necrotic nodules) and 5 cholangiocarcinomas (all resected)]. Eighty-one HI were hypervascular, 72 were benign [40 focal nodular hyperplasia (FNH), 8 adenoma and 24 hemangiomas) and 9 cancers (5 HCC, 4 metastases: 7 resected). Male gender [relative risk (RR) 2.70, confidence interval (CI) 1.69-3.51], age >45 years (RR 3.15, CI 2.71-3.89), tumour diameter >4 cm (RR 3.35, CI 3.13-4.01) and late (8 min) enhancement on magnetic resonace imaging (MRI) (RR 4.15, CI 3.01-4.79) were predictive of malignancy. CONCLUSIONS: HI constitute 10% of practice volume. 10% of hyper and hypovascular incidental lesions are malignant. Most can be treated aggressively after diagnosis.
OBJECTIVES:Hepatic incidentalomas (HI) are asymptomatic lesions detected incidentally during investigations for other pathologies. This prospective series outlines the management and outcomes of 121 HI managed over 7 years. METHODS: Data were recorded prospectively on 121 patients referred between 2003 and 2010 for assessment of HI out of 1081 patients referred for a hepatic resection. Patients were reviewed in multidisciplinary meetings and investigated with tumour markers and radiological investigations. HI were classified as hypo- or hypervascular depending on arterial phase CT scan findings. Univariate and multivariate analysis was performed to define predictive factors for malignancy. RESULTS: Forty HI were hypovascular, 35 were benign (18 cysts, 12 focal fatty sparing, 1 fetal lobulation and 4 solitary necrotic nodules) and 5 cholangiocarcinomas (all resected)]. Eighty-one HI were hypervascular, 72 were benign [40 focal nodular hyperplasia (FNH), 8 adenoma and 24 hemangiomas) and 9 cancers (5 HCC, 4 metastases: 7 resected). Male gender [relative risk (RR) 2.70, confidence interval (CI) 1.69-3.51], age >45 years (RR 3.15, CI 2.71-3.89), tumour diameter >4 cm (RR 3.35, CI 3.13-4.01) and late (8 min) enhancement on magnetic resonace imaging (MRI) (RR 4.15, CI 3.01-4.79) were predictive of malignancy. CONCLUSIONS:HI constitute 10% of practice volume. 10% of hyper and hypovascular incidental lesions are malignant. Most can be treated aggressively after diagnosis.
Authors: Michael S Rodgers; Rowan Collinson; Shashank Desai; Richard S Stubbs; John L McCall Journal: Dis Colon Rectum Date: 2003-04 Impact factor: 4.585
Authors: Michael G House; Hiromichi Ito; Mithat Gönen; Yuman Fong; Peter J Allen; Ronald P DeMatteo; Murray F Brennan; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica Journal: J Am Coll Surg Date: 2010-05 Impact factor: 6.113
Authors: Chi Leung Liu; Sheung Tat Fan; Chung Mau Lo; See Ching Chan; Wai Kuen Tso; Irene O Ng; John Wong Journal: J Gastrointest Surg Date: 2004-11 Impact factor: 3.452
Authors: Adam St J R Bartlett; John L McCall; Jonathan B Koea; Andrew Holden; Mee-Ling Yeong; Nishanthi Gurusinghe; Ed Gane Journal: World J Surg Date: 2007-07-04 Impact factor: 3.352
Authors: Wolfgang Kratzer; Beate Gruener; Tanja E M Kaltenbach; Sarina Ansari-Bitzenberger; Peter Kern; Michael Fuchs; Richard A Mason; Thomas F E Barth; Mark M Haenle; Andreas Hillenbrand; Suemeyra Oeztuerk; Tilmann Graeter Journal: World J Gastroenterol Date: 2015-11-21 Impact factor: 5.742
Authors: Katrin Hoffmann; Michael Unsinn; Ulf Hinz; Karl Heinz Weiss; Nina Waldburger; Thomas Longerich; Boris Radeleff; Peter Schirmacher; Markus W Büchler; Peter Schemmer Journal: HPB (Oxford) Date: 2015-09-03 Impact factor: 3.647
Authors: Hans Michael Hau; Georgi Atanasov; Hans-Michael Tautenhahn; Rudolf Ascherl; Georg Wiltberger; Markus Bo Schoenberg; Mehmet Haluk Morgül; Dirk Uhlmann; Michael Moche; Jochen Fuchs; Moritz Schmelzle; Michael Bartels Journal: Eur J Med Res Date: 2015-10-22 Impact factor: 2.175